FDA panel votes 16-2 AGAINST recommending to approve Pfizer booster shots to healthy people under 65 because there is not enough evidence they are safe and effective | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

FDA panel votes 16-2 AGAINST recommending to approve Pfizer booster shots to healthy people under 65 because there is not enough evidence they are safe and effective

An independent panel at the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend approval of booster doses for the Pfizer-BioNTech COVID-19 vaccine - but only for specific at-risk groups.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA